Wei Xia

25PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyProteins and peptidesMedical infection agents (incl. prions)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 26, 2026
Bacteria-Mediated Targeted Delivery and Deep Tumor Penetration of a Pt(IV)-Drug Enables Synergistic Chemo-Immunotherapy.

|Nov 30, 2025
Tricarbonyl Rhenium-Based PROTACs Degrade the SARS-CoV-2 Mpro Protease.

Liuruiqi Luo, Yuxiang Lu, He Meng

|Nov 11, 2025
Enabling the Identification of Dopamine Receptor Ligands from Complex Matrices Using a Cyclic Tetrapeptide.

Hongyu Wen, Zhisheng Lai, Jinhui Wang

|Feb 22, 2025
Targeting the Adenosine-Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo-Immunotherapy.

Jinhui Wang, Jing Wang, Zhijie Yu

|Sep 04, 2024
Complex structure and activation mechanism of arginine kinase McsB by McsA.

Kai Lu, Bingnan Luo, Xuan Tao

|Jun 28, 2024
G-quadruplex-guided cisplatin triggers multiple pathways in targeted chemotherapy and immunotherapy.

Tian-Zhu Ma, Liu-Yi Liu, You-Liang Zeng

Pageof 5

Frequent Collaborators

12 joint publications

Zong-Wan Mao

5 joint publications

Hongzhe Sun

3 joint publications

Hongyan Li

2 joint publications

Gangfeng Ouyang